DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
This grant funds innovative therapeutic ideas aimed at treating Amyotrophic Lateral Sclerosis (ALS).
About this program
The DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award supports groundbreaking research focused on developing new therapeutic approaches for ALS. This program is designed to encourage innovative ideas that can lead to significant advancements in the treatment of this debilitating disease. Researchers and organizations with promising concepts are invited to apply for funding to bring their ideas to fruition. The grant is open to a wide range of applicants, including academic institutions, nonprofit organizations, and private sector entities engaged in ALS research. The program aims to foster collaboration among researchers and stakeholders in the ALS community to accelerate the development of effective therapies. By providing financial support, the Therapeutic Idea Award seeks to empower researchers to explore novel solutions that could improve the quality of life for individuals affected by ALS.
Eligibility
Academic institutions, nonprofit organizations, and private sector entities engaged in ALS research.